These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4442440)

  • 1. The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
    Einarsson K; Hellström K; Kallner M
    Eur J Clin Invest; 1974 Dec; 4(6):405-10. PubMed ID: 4442440
    [No Abstract]   [Full Text] [Related]  

  • 2. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K; Einarsson K
    Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cholic acid feeding on bile acid kinetics and neutral fecal steroid excretion in hyperlipoproteinemia (types II and IV).
    Einarsson K; Hellström K; Kallner M
    Metabolism; 1974 Sep; 23(9):863-73. PubMed ID: 4851615
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of clofibrate on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.
    Einarsson K; Hellström K; Kallner M
    Eur J Clin Invest; 1973 Jul; 3(4):345-51. PubMed ID: 4760056
    [No Abstract]   [Full Text] [Related]  

  • 5. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K; Hellström K; Leijd B
    J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cholestyramine on bile acid metabolism in conventional rats.
    Imai Y; Kawata S; Inada M; Miyoshi S; Minami Y; Matsuzawa Y; Uchida K; Tarui S
    Lipids; 1987 Jul; 22(7):513-6. PubMed ID: 3626777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ileal bypass in the treatment of hyperlipoproteinaemia.
    Thompson GR; Gotto AM
    Lancet; 1973 Jul; 2(7819):35-6. PubMed ID: 4123303
    [No Abstract]   [Full Text] [Related]  

  • 8. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
    Glueck CJ; Ford S; Scheel D; Steiner P
    JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chenodeoxycholic acid on serum and biliary lipids in patients with hyperlipoproteinaemia.
    Angelin B; Einarsson K; Leijd B
    Clin Sci Mol Med; 1978 Apr; 54(4):451-5. PubMed ID: 639478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cholestyramine on bile acid kinetics in healthy controls.
    Andersén E
    Scand J Gastroenterol; 1979; 14(6):657-62. PubMed ID: 531498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
    Grundy SM; Ahrens EH; Salen G
    J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253
    [No Abstract]   [Full Text] [Related]  

  • 13. On the metabolism of cholesterol and bile acids in normo- and hyperlipidaemic subjects.
    Andersén E
    Acta Med Scand Suppl; 1980; 643():1-35. PubMed ID: 6935950
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunodeficiency, xanthomas and obstructive liver disease.
    Isenberg JN; Hanson RF; Williams GC; Zavoral J; Page AR; Sharp HL
    Am J Med; 1976 Sep; 61(3):393-400. PubMed ID: 961702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV.
    Kallner M
    J Lab Clin Med; 1975 Oct; 86(4):595-604. PubMed ID: 170347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
    Leijd B
    Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered bile acid metabolism during treatment with phenobarbitone.
    Miller NE; Nestel PJ
    Clin Sci Mol Med; 1973 Aug; 45(2):257-62. PubMed ID: 4361804
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of deoxycholic acid feeding on the elimination of cholesterol in normolipaemic subjects.
    Einarsson K; Hellström K; Kallner M
    Clin Sci Mol Med; 1974 Nov; 47(5):425-33. PubMed ID: 4611679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.